Moderna, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0QF.F | 261780.KQ | BAVA.CO | NVAX | VIR | LGND | |
|---|---|---|---|---|---|---|
| Market cap | 88.27B | 105.63B | 18.30B | 1.82B | 1.79B | 6.28B |
| P/E (TTM) | — | — | 12.5 | — | — | 33.2 |
| Forward P/E | — | — | 22.4 | -67.2 | -4.2 | 26.3 |
| Price/book | 14.6 | — | 1.4 | -9.5 | 1.8 | 6.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +822.88% | +50.85% | +0.08% | +31.70% | +75.49% | +65.11% |
| Today | +3.22% | −2.00% | +0.74% | −3.67% | −1.58% | +2.73% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 0QF.F news ›Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance?
The Globe and Mail Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance? Although ModernaMRNA initially established itself as a leading COVID-19 vaccine maker, the company is focused on broadening its commercial portfolio…
Moderna MRNA Breaks to a New 52-Week High at $242.08
As seen on the 24/7 Wall St. homepage on October 20, 2026. Moderna just set a fresh 52-week high at $242.08, 2.36% above the peak it reached on October 15. A year ago the stock traded near $27. Moderna hit a new 52-week high of $242.08 on…
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice
Moderna’s coronavirus vaccine generated blockbuster revenue, but demand declined in the later stages of the pandemic. The company’s oncology pipeline is advancing, and a potential product may be on the horizon. Recent years have been…
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
Moderna shares are surging ahead of a closely watched cancer data presentation in Madrid, but the company's razor-thin revenue base means a single readout could swing the stock sharply in either direction. Moderna‘s (NASDAQ:MRNA | MRNA…
Should You Sell Your Moderna Stock Now?
Little Of Moderna’s Price Comes From Today’s Sales Very little. Moderna stock trades at 40.9 times its sales over the past twelve months, compared with 3.1 times for the S&P 500. A price-to-earnings ratio is not meaningful for Moderna, as…
Moderna Inc Stock (MRNA) Moved Up by 5.69% on Oct 20: What Signal Does It Send?
Moderna Inc (MRNA) moved up by 5.69%. The Pharmaceuticals & Medical Research sector is up by 2.65%. The company outperformed the industry. Top 3 stocks by turnover in the sector: Eli Lilly and Co (LLY) up 4.23%; Moderna Inc (MRNA) up…
FILE PHOTO: An illustration photo shows a Moderna mFlusiva (Influenza Vaccine, mRNA) vaccine in Schwenksville
The Lufkin Daily News - Burke man suffers possibly life-threatening injuries in motorcycle crash on Highway 69 - Fast food just got faster with new White Castle kiosk at Murphy Express - Woman given 15-year sentence for hurting âMiracle…
Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results
Merck and Moderna Prepare FDA Filing for Personalized… inkl Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results Merck and Moderna are preparing to file their personalized…
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
Antibody-drug conjugates, a groundbreaking cancer vaccine under development by Merck and Moderna and a closely watched PD-1xVEGF bispecific therapy from Summit Therapeutics and Akeso will be top of mind when the world’s foremost oncology…
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
The recent meteoric rally of MRNA shares has made Moderna a massive company. Its market cap has grown so large, in fact, that it’s earned a place among Nasdaq’s largest listings. Regardless of its size, investors should remain focused on a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com19
-
tradingview.com19
-
247wallst.com16
-
gurufocus.com15
-
theglobeandmail.com13
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.